ABCG2 and neutropenia: There was heterogeneity between studies assessing the relationships of ABCG2 rs2231142 polymorphism with sunitinib-induced hypertension, HFS, and neutropenia (I2 = 61.4%, 68.3%, and 68.6%, respectively), and the random-effects model was applied to the analysis.